Yasunari Kashihara
Director/Board Member at ONCOLYS BIOPHARMA INC.
Net worth: 507 895 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Keiji Yoshimura | M | 68 |
Oncolys USA, Inc.
| 8 years |
| Yasuo Urata | M | 68 |
Oncolys USA, Inc.
| 20 years |
| Daniel Katzman | M | - |
Unleash Immuno Oncolytics, Inc.
 Unleash Immuno Oncolytics, Inc. BiotechnologyHealth Technology Unleash Immuno Oncolytics, Inc. develops oncolytic virus immunotherapy products to treat cancer. Its product is UIO-512. the company is headquartered in Saint Louis, MO.
Precision Virologics, Inc.
 Precision Virologics, Inc. BiotechnologyHealth Technology Precision Virologics, Inc. develops biologically targeted vaccines for emerging infectious diseases. The company was founded by David T. Curiel in 2017 and is headquartered in Saint Louis, MO. | - |
| Kohei Hata | M | - | 5 years | |
| Yasushi Saito | M | - | 2 years | |
| Charlie Bolten | M | - |
Unleash Immuno Oncolytics, Inc.
Unleash Immuno Oncolytics, Inc. BiotechnologyHealth Technology Unleash Immuno Oncolytics, Inc. develops oncolytic virus immunotherapy products to treat cancer. Its product is UIO-512. the company is headquartered in Saint Louis, MO. | - |
| Naoko Iino | F | 63 | 1 years | |
| Lisandro Bril | M | - |
Unleash Immuno Oncolytics, Inc.
Unleash Immuno Oncolytics, Inc. BiotechnologyHealth Technology Unleash Immuno Oncolytics, Inc. develops oncolytic virus immunotherapy products to treat cancer. Its product is UIO-512. the company is headquartered in Saint Louis, MO. | - |
| Katsufusa Tachiya | M | 73 | 13 years | |
| Bradford Young | M | - |
Liquid Biotech USA, Inc.
 Liquid Biotech USA, Inc. Medical/Nursing ServicesHealth Services Liquid Biotech USA, Inc. provides cancer diagnosing services. The private company is based in Philadelphia, PA. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Takashi Kamitani | M | - | 2 years | |
| Fumio Urano | M | 81 | - | |
| Mark Cruise | M | 53 |
Trinity College Dublin
| 3 years |
| Simon Hollingsworth | M | - |
Trinity College Dublin
| 4 years |
| Laura McCoy | F | - |
Trinity College Dublin
| 4 years |
| Simon English | M | - |
Trinity College Dublin
| 4 years |
| John Jeffery | M | - |
Trinity College Dublin
| 4 years |
| Jeanette Delehanty | F | - |
Trinity College Dublin
| 4 years |
| Lara Alice Pender | F | - |
Trinity College Dublin
| 4 years |
| Philip O'Reilly molten | M | - |
Trinity College Dublin
| 4 years |
| Rebecca Glenapp | F | - |
Trinity College Dublin
| 4 years |
| Louis J. Cantolupo | M | - |
Unleash Immuno Oncolytics, Inc.
Unleash Immuno Oncolytics, Inc. BiotechnologyHealth Technology Unleash Immuno Oncolytics, Inc. develops oncolytic virus immunotherapy products to treat cancer. Its product is UIO-512. the company is headquartered in Saint Louis, MO. | 3 years |
| David Hourihane | M | - |
Trinity College Dublin
| 4 years |
| Brian Hastings | M | - |
Trinity College Dublin
| 4 years |
| John Brian Aylward | M | 45 |
Trinity College Dublin
| 4 years |
| Michelle Dervan | F | - |
Trinity College Dublin
| 4 years |
| Naoki Kobayashi | M | 60 | 2 years | |
| Thomas Cooney | M | 60 |
Trinity College Dublin
| 3 years |
| Philip Michael Brides | M | - |
Trinity College Dublin
| 4 years |
| Gareth Stenson | M | - |
Trinity College Dublin
| 4 years |
| Darragh Curran | M | - |
Trinity College Dublin
| 4 years |
| Eoghan McCabe | M | 40 |
Trinity College Dublin
| 4 years |
| Cronan McNamara | M | - |
Trinity College Dublin
| 4 years |
| Pascal Casavecchia | M | - |
Trinity College Dublin
| 1 years |
| Takashi Morimoto | M | 78 | - | |
| Phil Byrne | M | - |
Trinity College Dublin
| 4 years |
| Stephanie Jepsen | F | - |
Trinity College Dublin
| 1 years |
| John Thomas Malone | M | - |
Trinity College Dublin
| 2 years |
| Conor Martin | M | - |
Trinity College Dublin
| 1 years |
| Noel Sullivan | M | - |
Trinity College Dublin
| 4 years |
| Alexandra Lemacon | F | - |
Trinity College Dublin
| 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Ireland | 26 | 63.41% |
| Japan | 10 | 24.39% |
| United States | 7 | 17.07% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Yasunari Kashihara
- Personal Network